Article
MicroRNAs in CSF as prodromal biomarkers for Huntington disease in the PREDICT-HD study
27 Dec 2017
Abstract excerpt
OBJECTIVE: To investigate the feasibility of microRNA (miRNA) levels in CSF as biomarkers for prodromal Huntington disease (HD). METHODS: miRNA levels were measured in CSF from 60 PREDICT-HD study participants using the HTG protocol. Using a CAG-Age Product score, 30 prodromal HD participants were selected based on estimated probability of imminent clinical diagnosis of HD (i.e., low, medium, high; n = 10/group)....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
